Related Experiment Video

Updated: Jul 4, 2026

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
08:15

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System

Published on: April 11, 2025

The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway

Seongmi Park1, Deepti B Ramnarain, Kimmo J Hatanpaa

  • 1Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8813, USA.

EMBO Reports
|June 21, 2008
PubMed

Insights

Receptor-interacting protein 1 (RIP1) controls cell proliferation by regulating p27Kip1 levels through a novel pathway. This finding offers new insights into inflammation-induced cancer and immune signaling.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Immunology

Background:

  • Inflammation and cell proliferation pathways are crucial in cancer pathogenesis.
  • Receptor-interacting protein 1 (RIP1) is a key mediator of inflammation-induced nuclear factor-kappaB (NF-kappaB) activation.

Purpose of the Study:

  • To investigate the role of RIP1 in regulating cell-cycle progression.
  • To elucidate the molecular mechanisms by which RIP1 influences cell proliferation pathways.

Main Methods:

  • Utilized RIP1-knockout mouse embryonic fibroblasts (MEFs).
  • Investigated RIP1's effect on p27Kip1 levels and cell-cycle progression.
  • Analyzed RIP1's regulation of the p27Kip1 promoter and transcription factors.

Main Results:

  • RIP1 regulates p27Kip1 levels via an NF-kappaB-independent pathway involving phosphatidylinositol 3-kinase (PI3K)-Akt-forkhead signaling.
  • RIP1 downregulates p27Kip1 at the mRNA level, promoting cell-cycle progression.
  • Overexpression of p27Kip1 counteracts RIP1's effects on the cell cycle.

Conclusions:

  • RIP1 plays a significant role in linking inflammatory signaling to cell-cycle control.
  • The PI3K-Akt-forkhead pathway is a critical mediator of RIP1's function in regulating p27Kip1.
  • Understanding this cross-talk provides novel insights into inflammation-induced cancer development.

More Related Videos

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells09:15

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells

Published on: October 20, 2022

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...